AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
228.72
-4.14 (-1.78%)
Feb 18, 2026, 4:00 PM EST - Market closed
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,112,000
Profits / Employee
$76,836
Market Cap
404.24B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | 0 | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 92,900 |
| Pfizer | 81,000 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Novo Nordisk | 69,505 |
| GSK plc | 68,629 |
| Eli Lilly and Company | 50,000 |
ABBV News
- 2 days ago - AbbVie: Dominating Immunology While Building Oncology Upside - Seeking Alpha
- 5 days ago - AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript - Seeking Alpha
- 6 days ago - 54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced' - Seeking Alpha
- 7 days ago - AbbVie sues US health agency over Botox price controls - Reuters
- 7 days ago - Abbvie sues US health agency over Botox - Reuters
- 7 days ago - 2 Urgent Sells And 2 No Brainer Dividend Buys - Seeking Alpha
- 8 days ago - Dividend Kings: No Ideal Buys In February's 57 - Seeking Alpha
- 13 days ago - AbbVie: The Market Is Getting It Wrong - Seeking Alpha